Cerakan HCT Tablet 10/40/12.5 mg

Adult dose

This medication should be taken once daily with water, regardless of meals. It is recommended to take it at the same time every day (e.g., in the morning). The recommended dosages are as follows: - 5/20/12.5 mg: For patients whose blood pressure is not appropriately controlled with amlodipine/olmesartan medoxomil combination therapy of 5/20 mg. - 5/40/12.5 mg: For patients whose blood pressure is not appropriately controlled with amlodipine/olmesartan medoxomil combination therapy of 5/40 mg.

Child dose

The safety and efficacy of this medication have not been established in pediatric patients under 18 years of age, so its use is not recommended.

This medication can cause serious harm to the fetus and newborn during the second and third trimesters of pregnancy, thus it should be discontinued immediately if pregnancy is confirmed. Patients with an allergy to this medication or any ingredients contained within, or those with specific heart, kidney, or liver diseases, as well as pregnant or breastfeeding women should not take this drug. Patients who have certain conditions, such as significantly low blood pressure, severe heart failure, or severely impaired kidney function, need to exercise special caution when using this medication. Due to the strong blood pressure-lowering effects of this drug, symptoms of blood pressure drop may occur upon initial intake; therefore, careful monitoring of the condition is necessary. If symptoms are severe, patients should lie down to rest and seek intravenous treatment if needed. This medication may affect kidney function, so patients with kidney disease should have their kidney function and electrolyte levels regularly checked by blood tests. Patients with liver disease or certain heart conditions should be cautious as hepatic coma or cardiovascular issues may arise while taking this medication. This medication can cause photosensitivity reactions; therefore, caution is advised when exposed to sunlight. It is recommended to stop taking the medication if adverse reactions occur. Dizziness or drowsiness may occur while taking this medication, so driving or operating hazardous machinery should be avoided. This drug may interact with other medications, so it is essential to inform the doctor or pharmacist of any other medications being taken. Overdose can result in symptoms like low blood pressure or palpitations; if symptoms are severe, it is imperative to visit a hospital for appropriate treatment. This medication has not been established for safety and efficacy in children, and therefore it is not recommended for use in this population. Elderly patients may experience enhanced effects from this medication due to decreased kidney and liver function, thus starting at a lower dose and careful monitoring is advised. During breastfeeding, the components of this medication may be transferred to breast milk, potentially affecting the infant; hence, it is recommended to either discontinue breastfeeding or this medication.

Serious side effects

Urticaria, severe swelling (edema), difficulty breathing, jaundice, severe allergic reactions, severe skin adverse reactions, serious neurological symptoms, severe edema or urination abnormalities, acute kidney failure, pulmonary edema, vasculitis (including necrotizing vasculitis), thrombosis, embolism, acute interstitial pneumonia, acute respiratory distress syndrome (ARDS), Stevens-Johnson syndrome, Quincke's edema, toxic skin necrosis, acute cholecystitis, hepatitis, acute respiratory distress syndrome

Mild side effects

• Peripheral edema
• headache
• dizziness
• upper respiratory tract infection
• nasopharyngitis
• urinary tract infection
• sialadenitis
• leukopenia
• thrombocytopenia
• bone marrow suppression

This medication should be stored in a tightly closed container to avoid exposure to air or moisture. It is advisable to keep it at room temperature between 1°C and 30°C.

Appearance

Round film-coated tablets with a grayish red color

Package unit

28 tablets (14 tablets/PTP x 2)/carton